Please join us in congratulating these talented researchers. 👏We’re excited to see where their Momentum Fellowships take them!
18.02.2026 21:21
👍 1
🔁 0
💬 0
📌 0
Please join us in congratulating these talented researchers. 👏We’re excited to see where their Momentum Fellowships take them!
Renewals cont'd:
🔬 Pablo Freire | PI: Scott Armstrong @danafarber.bsky.social
🔬 Júlia Matas | PI: @sj-dawson.bsky.social @petermaccc.bsky.social
🔬 Ping Wang | PI: @ejohnwherry.bsky.social @upenn.edu
2026 Fellowship renewals:
🔬 Thang DoCong | PI: @dannomura.bsky.social @ucberkeleyofficial.bsky.social
🔬 Hannah Fay | PI: @rosslevinemd.bsky.social @mskcancercenter.bsky.social
2026 Fellows:
🧬 dolfibastien.bsky.social | PI: @johannajoyce.bsky.social @unil.bsky.social
🧬 @brita-o.bsky.social | PI: Cath Bollard @childrensnational.bsky.social
🧬Constandina Pospori | PI: @charlesswanton.bsky.social @crick.ac.uk
🧬Emily Ringwalt | PI: Elaine Mardis @nationwidekids.bsky.social
The Mark Foundation is thrilled to announce our 2026 Momentum Fellows! 🚀
We are supporting 9 brilliant investigators—4 new recipients & 5 renewals—tackling everything from immunosuppression to CAR-T cell exhaustion.
Meet the future of cancer research:
themarkfoundation.org/2026/02/the-...
Huge congratulations to Mark Foundation grantees Catherine Wu & Darrell Irvine for being named to the 2026 @Time 100 Health list! 🏆
🧬Learn how their work is redefining the future of oncology.
themarkfoundation.org/blog/56202/
#TIME100 #CancerResearch
Together with the Sontag Foundation and our coalition partners, we are leaving no stone unturned in the pursuit of a cure for #glioblastoma. We are proud to support these scientists as they push the boundaries of what’s possible for patients worldwide. 🤝🚀
themarkfoundation.org/glioblastoma...
ASPIRE Award: Peter Sorger and Christine Brown are using spatial profiling to see exactly how CAR T cells interact with the tumor environment, helping to make immunotherapy more effective for brain cancer. 📍
ASPIRE Award: Daniel Schramek and Dan Wahl are using advanced screening to identify the specific genetic drivers behind both IDH-mutant and IDH-wildtype gliomas to find new drug targets. 🧬🔍
ASPIRE Award: Justin Lathia is investigating how platelets interact with immune cells in the brain to drive tumor growth and testing whether existing drugs can be repurposed to improve outcomes.🩸🧠
ASPIRE Award: E. Antonio Chiocca and Marco Mineo are developing antisense oligonucleotides as a new approach to shut down the immune-escape mechanisms that make it difficult to fight glioblastoma. 💉🛡️
Endeavor Award:
@rameenberoukhim.bsky.social, William Kaelin Jr., Keith Ligon, Daniel Schramek, and Jason Moffat are mapping aneuploidies—large-scale genetic changes—to find new therapeutic targets that exist in nearly every cell of a glioblastoma tumor. 🗺️🔬
📢 In partnership with the Sontag Foundation, @braintumor.org, the Southeastern Brain Tumor Foundation, the Uncle Kory Foundation & Fondation Anne et Claude Berda, we're committing new funding to 5 teams tackling the world’s most aggressive brain tumor. 🧠🧬
themarkfoundation.org/2026/02/the-...
We are proud to join forces with a new coalition of leading organizations including @theaacr.bsky.social, @break-cancer.bsky.social, @lustgarten.org & @themarkfdn.bsky.social! Together we will fund $12mm to 6 teams focused on early detection of some of the most challenging cancers including ovarian.
Learn more about their projects, the award program, and our collaboration with @theaacr.bsky.social , @lustgarten.org , @break-cancer.bsky.social and @tinaswish.bsky.social on our website: themarkfoundation.org/early-detection
@landau.bsky.social @rdrapkin8-penn.bsky.social Paul Mischel, and Adam Widman are searching for pre-cancerous signals of ovarian cancer in the blood, laying the foundation for non-invasive screening test. 🩸@tinaswish.bsky.social
@weillcornell.bsky.social @mskcancercenter.bsky.social
Peter Sorger, David Walt, Sandro Santagata, and @rdrapkin8-penn.bsky.social are mapping ovarian cancer precursors to enable detection and treatment of the disease while it is still localized. 🗺️💊 @break-cancer.bsky.social
@harvard.edu @pennmedicine.bsky.social
Christina Curtis, Greg Charville, William Grady, and Rebecca Fitzgerald are using AI & advanced computational tools to spot early warning signs in the esophagus before cancer develops. 🖥️🔍 @break-cancer.bsky.social
@stanford-cancer.bsky.social
Trevor Pugh, Brian Crompton, @doctorpauln77.bsky.social, and @karanoelle.bsky.social are developing an accurate, accessible blood test for patients with very high inherited cancer risk due to conditions such as Li-Fraumeni Syndrome. 🧬
@stjuderesearch.bsky.social
@danafarber.bsky.social
Brian Wolpin, Andrew Aguirre, Julie Sutcliffe, and Laura Wood are using new drugs to detect and "label" pre-cancerous lesions in the pancreas and prevent their progression to advanced cancer. 🛑
@danafarber.bsky.social
@ucdavis.bsky.social
Nikolaos Sgourakis, Mark Sellmyer, & @possuhuanglab.bsky.social are developing radioactive imaging agents to detect KRAS mutations, which drive 90% of pancreatic tumors but can’t currently be seen on scans. ☢️
@stanford.edu
@upenn.edu
📢 Announcing the 2026 Early Detection Award recipients! 📢
In partnership with @theaacr.bsky.social, @lustgarten.org, @break-cancer.bsky.social, and @tinaswish.bsky.social, we are committing $12 million to 6 teams developing new diagnostic approaches for the world’s deadliest cancers. 🧬🔬
In an increasingly uncertain funding environment, how can philanthropy effectively support cancer research? In After Treatment, CEO Ryan Schoenfeld tells
@grogowl.bsky.social how The Mark Foundation continues to advance game-changing science.
www.after-treatment.com/p/where-is-t...
Honored to receive the EACR Rising Star Award 2026.
Thanks to @helloeacr.bsky.social, @themarkfdn.bsky.social, and the Pezcoller Foundation for the support.
This backs a vision we deeply believe in: time-resolved dynamics are key in cancer–immune interactions.
tinyurl.com/45vpm3rr
Congratulations to Daniel Birschenkaum of @dkfz.bsky.social, the 2026 recipient of the @helloeacr.bsky.social-Mark Foundation-Pezcoller Rising Star Award! The award will support his work exploring the dynamic behavior of immune cells in brain tumors. themarkfoundation.org/2026/01/dani...
🚨 New research from the CancerGrand Challenges SPECIFICANCER team (co-funded by The Mark Foundation & @cancerresearchuk.org) highlights NPM1 as a promising target for bowel & liver cancer.
Read more in @the-independent.com:
www.independent.co.uk/news/health/...
Congratulations to Mark Foundation Scientific Advisory Committee chair and Board member @rosslevinemd.bsky.social !
Since 2018, the ELA program has awarded over $40M to spark innovation. This year, we are also proud to partner with The Bakewell Foundation to support Jeremy Borniger’s unconventional and bold research. 🤝
Christopher Johnston is engineering human-derived bacteria to act as "cellular therapies," infiltrating solid tumors to deliver medicine directly into the most treatment-resistant environments. 🧫 @mdanderson.bsky.social
Mariella Filbin is exploring how aggressive childhood brain tumors hijack normal brain activity to repair their own DNA. This research aims to break through radiation resistance in diffuse midline gliomas. 🧠 @danafarbernews.bsky.social